Thierry Lamy

12.1k total citations
177 papers, 6.4k citations indexed

About

Thierry Lamy is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Thierry Lamy has authored 177 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Pathology and Forensic Medicine, 74 papers in Genetics and 62 papers in Oncology. Recurrent topics in Thierry Lamy's work include Lymphoma Diagnosis and Treatment (86 papers), Chronic Lymphocytic Leukemia Research (60 papers) and Immune Cell Function and Interaction (28 papers). Thierry Lamy is often cited by papers focused on Lymphoma Diagnosis and Treatment (86 papers), Chronic Lymphocytic Leukemia Research (60 papers) and Immune Cell Function and Interaction (28 papers). Thierry Lamy collaborates with scholars based in France, United States and United Kingdom. Thierry Lamy's co-authors include Thomas P. Loughran, Thierry Fest, Aline Moignet, Karin Tarte, Céline Pangault, Gilles Salles, Patricia Amé-Thomas, Bernard Drénou, Nöel Milpied and Jin Hong Liu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Thierry Lamy

173 papers receiving 6.3k citations

Peers

Countries citing papers authored by Thierry Lamy

Since Specialization

Citations

This map shows the geographic impact of Thierry Lamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lamy more than expected).

Fields of papers citing papers by Thierry Lamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Lamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lamy. The network helps show where Thierry Lamy may publish in the future.

Co-authorship network of co-authors of Thierry Lamy

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Lamy. A scholar is included among the top collaborators of Thierry Lamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Lamy. Thierry Lamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Initial clinical data from the phase 1 study of DR-01, a non-fucosylated anti-CD94 antibody in patients with large granular lymphocytic leukemia 2025 ·Blood ·Enrica Marchi, Tapan M. Kadia, (unknown), Christina Poh, Costas K. Yannakou, Mitul Gandhi, Jasmine Zain, Sarah McCue Horwitz, J. Brian Reed, Jennifer Richardson, (unknown), Kimberley Dilley, Wan‐Jen Hong, Nenad Tomas̆ević, Natali Pflug, Thierry Lamy, Marco Herling, Jonathan E. Brammer, Thomas P. Loughran	0
2	Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia 2024 ·British Journal of Haematology ·Tony Marchand, Cédric Pastoret, Gandhi Damaj, (unknown), Charles Herbaux, Aline Moignet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Aspasia Stamatoullas, Christer Nilsson, (unknown), (unknown), Thierry Lamy	6
3	The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity 2023 ·Clinical Cancer Research ·Fabienne Desmots, Delphine Rossille, Mikaël Roussel, Céline Pangault, (unknown), (unknown), Steven Le Gouill, Krimo Bouabdallah, Vincent Delwail, Rémy Gressin, Jérôme Cornillon, Gandhi Damaj, Hervé Maisonneuve, Diane Damotte, Françoise Kraeber‐Bodéré, Thierry Lamy, Marie Parrens, Nöel Milpied, Thierry Fest	1
4	Immunochemotherapy versus rituximab in anti‐myelin‐associated glycoprotein neuropathy: A report of 64 patients 2022 ·British Journal of Haematology ·(unknown), Amandine Baptiste, Lisa Belin, Pascale Ghillani‐Dalbin, (unknown), Sylvain Choquet, Thierry Lamy, Véronique Morel, Lucile Musset, Damien Roos‐Weil, Karine Viala, Véronique Leblond, Marine Baron	4
5	Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells 2021 ·Blood ·Cédric Pastoret, Fabienne Desmots, (unknown), Simon Le Gallou, Marie‐Laure Boulland, (unknown), (unknown), Véronique Salaün, Gandhi Damaj, Richard Veyrat‐Masson, Olivier Tournilhac, Aline Moignet, Céline Pangault, Mikaël Roussel, Thierry Fest, Thierry Lamy	35
6	Final Long-Term Results from the Defifrance Registry Study: Efficacy and Safety of Defibrotide for the Treatment of Severe/Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation 2021 ·Blood ·Mohamad Mohty, Didier Blaise, Régis Peffault de Latour, Myriam Labopin, Marie Y. Detrait, Stéphane Girault, Anne Huynh, Hélène Labussière‐Wallet, Thierry Lamy, Delphine Lebon, Sébastien Maury, C. Rénard, Kobby Asubonteng, (unknown), Ibrahim Yakoub‐Agha, Jean‐Hugues Dalle	0
7	Identifying frailty in clinically fit patients diagnosed with hematological malignancies using a simple clinico-biological screening tool: The HEMA-4 study 2021 ·Journal of Geriatric Oncology ·(unknown), (unknown), (unknown), Cindy Kenis, Michel Delforge, C. Cattenoz, Dominique Somme, Hans Wildiers, Thierry Pepersack, Thierry Lamy, Dominique Bron	7
8	Integrative Analysis of Cell Crosstalk within Follicular Lymphoma Cell Niche: Towards a Definition of the FL Supportive Synapse 2020 ·Cancers ·Céline Pangault, Patricia Amé-Thomas, Delphine Rossille, Joëlle Dulong, Gersende Caron, (unknown), Fabrice Chatonnet, Fabienne Desmots, (unknown), Thierry Lamy, Thierry Fest, Karin Tarte	14
9	Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma 2018 ·Clinical Cancer Research ·Fabienne Desmots, Mikaël Roussel, Céline Pangault, Francisco Llamas‐Gutierrez, Cédric Pastoret, (unknown), Jérôme Le Priol, Valérie Camara‐Clayette, Gersende Caron, Cathérine Henry, Marc‐Antoine Belaud‐Rotureau, Pascal Godmer, Thierry Lamy, Fabrice Jardin, Karin Tarte, Vincent Ribrag, Thierry Fest	19
10	Prospective subgroup analyses of the randomized MCL‐002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma 2017 ·British Journal of Haematology ·Luca Arcaini, Thierry Lamy, Jan Walewski, David Belada, Jiří Mayer, John Radford, Wojciech Jurczak, Franck Morschhauser, (unknown), Simon Rule, José Cabeçadas, Elı́as Campo, Stefano Pileri, Tsvetan Biyukov, Meera Patturajan, (unknown), Marek Trněný, (unknown)	9
11	T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells 2016 ·Blood ·Imane Azzaoui, Fabrice Uhel, Delphine Rossille, Céline Pangault, Joëlle Dulong, Jérôme Le Priol, Thierry Lamy, Roch Houot, Steven Le Gouill, Guillaume Cartron, Pascal Godmer, Krimo Bouabdallah, Nöel Milpied, Gandhi Damaj, Karin Tarte, Thierry Fest, Mikaël Roussel	123
12	DC-SIGN–expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma 2015 ·Blood ·Rada Amin, Frédéric Mourcin, Fabrice Uhel, Céline Pangault, Philippe Ruminy, Loı̈c Dupré, (unknown), Tony Marchand, Thierry Fest, Thierry Lamy, Karin Tarte	92
13	COX-2–Independent Effects of Celecoxib Sensitize Lymphoma B Cells to TRAIL-Mediated Apoptosis 2014 ·Clinical Cancer Research ·Anne-Sophie Gallouët, Marion Travert, Laurence Bresson‐Bepoldin, Fabien Guilloton, Céline Pangault, Sylvie Caulet-Maugendre, Thierry Lamy, Karin Tarte, Thierry Guillaudeux	35
14	Report of 6 Cases of Large Granular Lymphocytic Leukemia and Plasma Cell Dyscrasia 2014 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Giampaolo Talamo, Jozef Malysz, (unknown), Thierry Lamy, Thomas P. Loughran	8
15	Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients 2014 ·Annals of Oncology ·Elsa Poullot, Renato Zambello, Francis LeBlanc, Benoît Bareau, (unknown), Mikaël Roussel, Marie‐Laure Boulland, Roch Houot, (unknown), Thierry Fest, Gianpietro Semenzato, Thomas P. Loughran, Thierry Lamy	45
16	Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor? 2010 ·Blood ·Hervé Avet‐Loiseau, Florent Malard, L. Campion, Florence Magrangeas, Catherine Sebban, Bruno Lioure, Olivier Decaux, Thierry Lamy, Laurence Legros, Jean‐Gabriel Fuzibet, Mauricette Michallet, Bernadette Corront, Pascal Lenain, Cyrille Hulin, Claire Mathiot, Michel Attal, Thierry Façon, Jean‐Luc Harousseau, Stéphane Minvielle, Philippe Moreau, (unknown)	92
17	Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase 2009 ·Cancer Research ·Hélène Maby–El Hajjami, Patricia Amé-Thomas, Céline Pangault, Olivier Tribut, John De Vos, Rachel Jean, Nadège Bescher, Céline Monvoisin, Joëlle Dulong, Thierry Lamy, Thierry Fest, Karin Tarte	65
18	CD40 Ligand Protects from TRAIL-Induced Apoptosis in Follicular Lymphomas through NF-κB Activation and Up-Regulation of c-FLIP and Bcl-xL 2008 ·The Journal of Immunology ·Marion Travert, Patricia Amé-Thomas, Céline Pangault, Alexandre Morizot, Olivier Micheau, G. Sémana, Thierry Lamy, Thierry Fest, Karin Tarte, Thierry Guillaudeux	71
19	Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis 2006 ·Blood ·Patricia Amé-Thomas, Hélène Maby–El Hajjami, Céline Monvoisin, Rachel Jean, Delphine Monnier, Sylvie Caulet-Maugendre, Thierry Guillaudeux, Thierry Lamy, Thierry Fest, Karin Tarte	177
20	Spectre des proliférations LGL et nouveaux concepts physiopathogéniques 1999 ·Hématologie ·Thierry Lamy, M. Hamidou, Thomas P. Loughran	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact